GAMIDA CELL Trademark

Trademark Overview

On Friday, September 6, 2019, a trademark application was filed for GAMIDA CELL with the United States Patent and Trademark Office. The USPTO has given the GAMIDA CELL trademark a serial number of 88606995. The federal status of this trademark filing is REGISTERED as of Tuesday, July 11, 2023. This trademark is owned by Gamida Cell Inc.. The GAMIDA CELL trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Cell therapy pharmaceutical preparations; pharmaceutical preparations in the field of hematology, oncology, leukemia, and blood and bone marrow diseases and disorders

Research and development in the fields of pharmaceuticals, cell therapies, hematology, leukemia, oncology, and blood and bone marrow diseases and disorders; providing medical and scientific research information in the fields of pharmaceuticals, cell therapies, hematology, leukemia, oncology, and blood and bone marrow diseases and disorders
gamida cell

General Information

Serial Number88606995
Word MarkGAMIDA CELL
Filing DateFriday, September 6, 2019
Status700 - REGISTERED
Status DateTuesday, July 11, 2023
Registration Number7108147
Registration DateTuesday, July 11, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 3, 2020

Trademark Statements

Goods and ServicesCell therapy pharmaceutical preparations; pharmaceutical preparations in the field of hematology, oncology, leukemia, and blood and bone marrow diseases and disorders
Translation of Words in MarkThe wording "GAMIDA" has no meaning in a foreign language.
Disclaimer with Predetermined Text"CELL"
Goods and ServicesResearch and development in the fields of pharmaceuticals, cell therapies, hematology, leukemia, oncology, and blood and bone marrow diseases and disorders; providing medical and scientific research information in the fields of pharmaceuticals, cell therapies, hematology, leukemia, oncology, and blood and bone marrow diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 17, 2019
Primary Code005
First Use Anywhere DateTuesday, April 19, 2022
First Use In Commerce DateTuesday, April 19, 2022
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 17, 2019
Primary Code042
First Use Anywhere DateTuesday, April 19, 2022
First Use In Commerce DateTuesday, April 19, 2022

Trademark Owner History

Party NameGAMIDA CELL LTD.
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressKIRYAT GAT 82584120
IL
Party NameGamida Cell Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116
Party NameGamida Cell Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02116
Party NameGamida Cell Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Trademark Events

Event DateEvent Description
Wednesday, March 27, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, July 11, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 11, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, June 8, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, June 7, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 2, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, April 28, 2023USE AMENDMENT FILED
Friday, April 28, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, November 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 31, 2022SOU EXTENSION 5 GRANTED
Thursday, October 20, 2022SOU EXTENSION 5 FILED
Monday, October 31, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 20, 2022SOU TEAS EXTENSION RECEIVED
Friday, April 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 20, 2022SOU EXTENSION 4 GRANTED
Wednesday, April 20, 2022SOU EXTENSION 4 FILED
Wednesday, April 20, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, February 15, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 15, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, February 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 15, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, October 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 28, 2021SOU EXTENSION 3 GRANTED
Thursday, October 28, 2021SOU EXTENSION 3 FILED
Thursday, October 28, 2021SOU TEAS EXTENSION RECEIVED
Saturday, April 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 8, 2021SOU EXTENSION 2 GRANTED
Thursday, April 8, 2021SOU EXTENSION 2 FILED
Thursday, April 8, 2021SOU TEAS EXTENSION RECEIVED
Saturday, October 3, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 1, 2020SOU EXTENSION 1 GRANTED
Thursday, October 1, 2020SOU EXTENSION 1 FILED
Thursday, October 1, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, April 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 3, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 3, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 12, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 29, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 29, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 29, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 28, 2020ASSIGNED TO LIE
Tuesday, January 21, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 16, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 16, 2019NON-FINAL ACTION E-MAILED
Monday, December 16, 2019NON-FINAL ACTION WRITTEN
Monday, December 9, 2019ASSIGNED TO EXAMINER
Tuesday, September 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 10, 2019NEW APPLICATION ENTERED

Related Keywords

cell gamida bone blood diseases disorders leukemia marrow oncology hematology research